Brown-Forman ( BF.B) earnings estimates were updated after reporting fourth quarter results, said UBS. FY13 EPS was reduced by $0.02 to $2.70 and FY14 EPS was increased by $0.04 to $3.14. Based on the new FY14 EPS estimate, the price target was increased to $75, said UBS.

Impax Labs ( IPXL) earnings estimates were reduced, said UBS. A new 483 warning letter had a lot more extensive issues, leading to uncertainty, said UBS. Price target was reduced to $17.

Newcastle Investment ( NCT) earnings estimates were increased through 2014 after reporting fourth quarter results, said UBS. The update includes the announcement to acquire a 50% interest in a consumer loan portfolio from HSBC, said UBS. Price target increased to $14.

Staples ( SPLS) earnings estimates through FY2014 were reduced after reporting fourth quarter results, said UBS. Aggressive sales guidance leads to uncertainty and the ODP/OMX merger will over shadow the stock, said UBS. Price target remains $13.

Shares of Time Warner ( TWX) now seen reaching $61, according to Credit Suisse. Spin-off of the publishing unit should help unlock value, according to Credit Suisse. Outperform rating.

Exxon Mobil ( XOM) earnings estimates were reduced, said UBS. The company provided a weaker than expected production outlook at its analysts meeting, said UBS. Price target remains $91.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Hurricane Harvey Isn't the Bruising Storm That Wall Street Hates: Market Recon

Big Lots Should Have a Good Quarter, Jim Cramer Explains

A Measured Fed and Retail Relief Rally Give Wall Street a Small Lift

Stocks Inch Higher as Fed Signals September as Start of Balance Sheet Reduction